Lifecore Biomedical, Inc.
USD5.07
+0.11 (+2.22%)
CEO
Paul Josephs
IPO Date
1996-02-15
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$4.95
Prev. Close
$4.96
Day Low
$4.83
Day High
$5.23
52W Low
$3.63
52W High
$8.98
Market Cap
$0.19B
Volume
0.20M
| 26 May 2024 | FY | 32.6% | 9.4% | 106.2% | 4.7% | 11.81 | 2.08 | 14.3 |
| 28 May 2023 | FY | 27.1% | -96.4% | 2353.7% | -39.3% | -26.63 | 2.39 | -2.4 |
| 29 May 2022 | FY | 35.1% | -104.9% | -132.9% | -42.5% | 2.82 | 0.66 | -2.5 |
| 31 May 2021 | FY | 38.6% | -32.0% | -15.9% | -6.4% | 1.06 | 1.46 | -10.6 |
| 31 May 2020 | FY | 24.6% | -23.9% | -16.5% | -7.1% | 0.96 | 0.96 | -8.3 |
| 31 May 2019 | FY | 14.5% | 0.4% | 0.8% | 0.4% | 0.56 | 0.97 | 132.6 |
| 31 May 2018 | FY | 14.9% | 4.7% | 9.8% | 6.1% | 0.29 | 1.10 | 15.7 |
| 31 May 2017 | FY | 15.6% | 2.0% | 4.7% | 3.0% | 0.24 | 1.58 | 36.4 |
| -9.6 |
| 31 Dec 2025 | Q4 | 0.0% | 0.0% | 0.0% | 0.0% | -10.04 | 3.49 | 0.0 |
| 30 Sept 2025 | Q1 | 25.0% | -32.1% | -27.2% | -4.2% | 3.74 | 2.80 | -6.9 |
| 25 May 2025 | Q4 | 38.4% | -3.1% | -85.9% | -0.5% | 97.92 | 2.84 | -54.2 |
| 23 Feb 2025 | Q3 | 28.0% | -42.0% | -662.6% | -6.2% | 58.48 | 2.71 | -3.5 |
| 24 Nov 2024 | Q2 | 34.0% | -20.2% | -42.5% | -2.6% | 8.50 | 2.32 | -9.8 |
| 25 Aug 2024 | Q1 | 21.8% | -65.7% | 412.1% | -6.6% | -34.75 | 1.83 | -3.0 |
| 26 May 2024 | Q4 | 45.6% | -18.7% | -62.6% | -2.8% | 11.81 | 2.08 | -6.1 |
| 25 Feb 2024 | Q3 | 33.3% | 43.8% | 88.4% | 6.3% | 7.14 | 2.07 | 4.1 |